
zzso are standard treatment for zzso bone disease, a common feature of many advanced zzso zzso used to inhibit bone turnover and reduce the risk of zzso events, there is now increasing zzso evidence that these agents may also affect zzso burden and disease zzso In particular, combining zzso with zzso agents has been demonstrated to cause substantially increased zzso effects compared to giving the single zzso Clinical studies are in progress to determine whether adding zzso to standard zzso therapy results in improved outcome for zzso Here we give an overview of the key zzso studies of zzso effects of zzso alone and in combination with other agents, and introduce some of the ongoing clinical trials that aim to determine the clinical relevance of zzso in combination zzso 

